Product NDC: | 45802-038 |
Proprietary Name: | erythromycin |
Non Proprietary Name: | erythromycin |
Active Ingredient(s): | 20 mg/mL & nbsp; erythromycin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-038 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063038 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111219 |
Package NDC: | 45802-038-46 |
Package Description: | 1 BOTTLE in 1 CARTON (45802-038-46) > 60 mL in 1 BOTTLE |
NDC Code | 45802-038-46 |
Proprietary Name | erythromycin |
Package Description | 1 BOTTLE in 1 CARTON (45802-038-46) > 60 mL in 1 BOTTLE |
Product NDC | 45802-038 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | erythromycin |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 20111219 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | ERYTHROMYCIN |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |